0
0This research presents an integrated clinicogenomic analysis of more than 7,000 colorectal cancer (CRC) cases, linking genetic evolution to patient outcomes. The study highlights how recurrent oncogenic mutations are often clonal and further amplified by allelic imbalance, which intensifies their biological impact. By tracking these changes, the authors identified distinct metastatic patterns, noting that certain pathways, like RAS, increase the risk of spread to all organs. Conversely, the WNT pathway appears to offer some protection against extensive metastasis. These findings culminated in the development of an organ-specific risk model that uses primary tumor location and genomics to predict where cancer may spread. Ultimately, the work clarifies how genomic dosage and timing influence the progression of advanced disease.
References:
Manca P, Walch H, Xu J, et al. Integrated clinicogenomic analysis reveals the evolution and metastatic tropisms of advanced colorectal cancer[J]. Cancer cell, 2026.
